Arkolith/Insider Trading/OCUL/Form 4

Notman Donald

Chief Operating OfficerOCULAR THERAPEUTIX, INC (OCUL) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$101K
Net Open-Market Flow
-$101K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2026Sell(S)6K$8.54$52K378K
Feb 2, 2026Sell(S)5K$9.14$50K384K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-010462) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML